PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 80 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $871,733 | +46.7% | 84,063 | +102.6% | 0.00% | +100.0% |
| Q2 2023 | $594,280 | +186.0% | 41,500 | +42.6% | 0.00% | 0.0% |
| Q1 2023 | $207,774 | -30.3% | 29,100 | -17.6% | 0.00% | 0.0% |
| Q2 2022 | $298,000 | -45.5% | 35,304 | -12.2% | 0.00% | -50.0% |
| Q1 2022 | $547,000 | -56.4% | 40,216 | -37.0% | 0.00% | -33.3% |
| Q4 2021 | $1,255,000 | +73.3% | 63,796 | +182.8% | 0.00% | +50.0% |
| Q3 2021 | $724,000 | -46.5% | 22,555 | -43.6% | 0.00% | -33.3% |
| Q2 2021 | $1,353,000 | -34.1% | 39,984 | -26.8% | 0.00% | -40.0% |
| Q1 2021 | $2,053,000 | – | 54,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |